Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Screening and breast cancer mortality--letter.

Bell RJ, Burton RC.

Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2275; author reply 2276-7. doi: 10.1158/1055-9965.EPI-12-1088. Epub 2012 Oct 23. No abstract available.

2.

Letter in response: the value of mammography screening.

Burton RC, Bell RJ.

Breast Cancer Res Treat. 2012 Aug;134(3):1345-6. doi: 10.1007/s10549-012-2064-y. Epub 2012 Apr 19. No abstract available.

PMID:
22527110
3.
4.

Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.

Burton RC, Bell RJ, Thiagarajah G, Stevenson C.

Breast Cancer Res Treat. 2012 Feb;131(3):949-55. doi: 10.1007/s10549-011-1794-6. Epub 2011 Sep 29.

PMID:
21956213
5.

The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences.

Mohebbi M, Wolfe R, Jolley D, Forbes AB, Mahmoodi M, Burton RC.

Int J Health Geogr. 2011 Feb 15;10:13. doi: 10.1186/1476-072X-10-13.

6.

Natural cytotoxicity of NC-2+ cells against the growth and metastasis of WEHI-164 fibrosarcoma.

Shirzad H, Burton RC, Smart YC, Rafieian-kopaei M, Shirzad M.

Scand J Immunol. 2011 Feb;73(2):85-90. doi: 10.1111/j.1365-3083.2010.02481.x.

7.

The relationship between solution structure and crystal nucleation: a neutron scattering study of supersaturated methanolic solutions of benzoic acid.

Burton RC, Ferrari ES, Davey RJ, Finney JL, Bowron DT.

J Phys Chem B. 2010 Jul 8;114(26):8807-16. doi: 10.1021/jp103099j.

PMID:
20550207
8.

Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic Heller myotomy for achalasia.

Snyder CW, Burton RC, Brown LE, Kakade MS, Finan KR, Hawn MT.

J Gastrointest Surg. 2009 Dec;13(12):2095-103. doi: 10.1007/s11605-009-1049-6. Epub 2009 Sep 30.

PMID:
19789928
9.

Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial.

Menzies SW, Emery J, Staples M, Davies S, McAvoy B, Fletcher J, Shahid KR, Reid G, Avramidis M, Ward AM, Burton RC, Elwood JM.

Br J Dermatol. 2009 Dec;161(6):1270-7. doi: 10.1111/j.1365-2133.2009.09374.x. Epub 2009 Jun 27.

PMID:
19747359
10.

Relationship between solution structure and phase behavior: a neutron scattering study of concentrated aqueous hexamethylenetetramine solutions.

Burton RC, Ferrari ES, Davey RJ, Finney JL, Bowron DT.

J Phys Chem B. 2009 Apr 30;113(17):5967-77. doi: 10.1021/jp811515u.

PMID:
19351125
11.

The nucleation of inosine: the impact of solution chemistry on the appearance of polymorphic and hydrated crystal forms.

Chiarella RA, Gillon AL, Burton RC, Davey RJ, Sadiq G, Auffret A, Cioffi M, Hunter CA.

Faraday Discuss. 2007;136:179-93; discussion 213-29.

PMID:
17955810
12.

The success and unrealised potential of the National Cancer Control Initiative.

Elwood JM, Burton RC, Quinn MA.

Med J Aust. 2006 Aug 7;185(3):183-4. No abstract available.

PMID:
16893372
13.

Simulation of phase separation in alcohol/water mixtures using two-body force field and standard molecular dynamics.

Ferrari ES, Burton RC, Davey RJ, Gavezzotti A.

J Comput Chem. 2006 Aug;27(11):1211-9.

PMID:
16755646
14.

Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.

Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG.

Med J Aust. 2006 Jan 2;184(1):6-10.

PMID:
16398622
15.

Passive smoking and breast cancer: is the evidence for cause now convincing?

Elwood JM, Burton RC.

Med J Aust. 2004 Sep 6;181(5):236-7. No abstract available.

PMID:
15347266
16.

Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners.

English DR, Del Mar C, Burton RC.

Med J Aust. 2004 Jan 5;180(1):16-9.

PMID:
14709122
17.

Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice.

English DR, Burton RC, del Mar CB, Donovan RJ, Ireland PD, Emery G.

BMJ. 2003 Aug 16;327(7411):375.

18.

Cancer control in Australia: into the 21(st) Century.

Burton RC.

Jpn J Clin Oncol. 2002 Mar;32 Suppl:S3-9.

PMID:
11959870
19.

Malignant melanoma in the year 2000.

Burton RC.

CA Cancer J Clin. 2000 Jul-Aug;50(4):209-13. Review. No abstract available.

20.

Active and passive cigarette smoking and breast cancer: is a real risk emerging?

Burton RC, Sulaiman N.

Med J Aust. 2000 Jun 5;172(11):550-2. No abstract available.

PMID:
10920754
21.

Surgery and cancer: opinion, evidence, and proof.

Burton RC.

J Surg Oncol. 1999 May;71(1):1-3. Review. No abstract available.

PMID:
10362083
22.

General practitioner screening for melanoma: sensitivity, specificity, and effect of training.

Burton RC, Howe C, Adamson L, Reid AL, Hersey P, Watson A, Watt G, Relic J, Holt D, Thursfield V, Clarke P, Armstrong BK.

J Med Screen. 1998;5(3):156-61.

PMID:
9795877
23.

Screening for colorectal cancer--the AHTAC report: where do we go from here?

Burton RC.

Aust N Z J Public Health. 1998;22(3 Suppl):300-1. No abstract available.

PMID:
9629811
24.
25.

Non-metastasizing melanoma?

Burton RC, Armstrong BK.

J Surg Oncol. 1998 Feb;67(2):73-6. Review. No abstract available.

PMID:
9486776
26.

Quality of life after surgery for early breast cancer.

Burton RC.

Aust N Z J Surg. 1997 Nov;67(11):749. No abstract available.

PMID:
9396987
27.

The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells.

Clarke GR, Burton RC, Smart YC.

Cancer Immunol Immunother. 1997 Oct;45(2):115-8.

PMID:
9390203
28.

Daffodils and cancer.

Burton RC, Armstrong BK.

Med J Aust. 1997 Aug 18;167(4):180-1. No abstract available.

PMID:
9293259
29.

TNF-alpha is not the sole mediator of WEHI-164 tumour cell killing in natural cytotoxicity.

Clarke GR, Shirzadeh H, Pang G, Beagley KW, Burton RC, Smart YC.

Cytokine. 1997 Apr;9(4):254-62.

PMID:
9112334
30.

Phosphorylation of the NC-1.1 receptor and regulation of natural cytotoxicity by protein kinase C and cyclic GMP-dependent protein kinase.

Holmgreen SP, Wang X, Clarke GR, Noltorp RS, Roberts TK, Burton RC, Robinson PJ, Smart YC.

J Immunol. 1997 Mar 1;158(5):2035-41.

PMID:
9036946
31.
32.

An IL-3-induced splenic NC-1.1+ mast cell line mediates natural cytotoxicity independent of TNF-alpha.

Shirzadeh H, Clarke GR, McNeil HP, Wang H, Burton RC, Smart YC.

Cell Immunol. 1996 Dec 15;174(2):147-54.

PMID:
8954614
34.

Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ.

BMJ. 1996 May 4;312(7039):1121-5.

35.

Screening for melanoma by primary health care physicians: a cost-effectiveness analysis.

Girgis A, Clarke P, Burton RC, Sanson-Fisher RW.

J Med Screen. 1996;3(1):47-53.

PMID:
8861052
36.

Current melanoma epidemic: a nonmetastasizing form of melanoma?

Burton RC, Armstrong BK.

World J Surg. 1995 May-Jun;19(3):330-3. Review.

PMID:
7638981
37.
38.
39.

Phenotype and morphology of murine NC-1.1+ natural cytotoxic cells.

Brien JH, Smart YC, Farrelly ML, Burton RC.

Immunol Cell Biol. 1994 Apr;72(2):161-8.

PMID:
8200691
40.

Recent incidence trends imply a nonmetastasizing form of invasive melanoma.

Burton RC, Armstrong BK.

Melanoma Res. 1994 Apr;4(2):107-13.

PMID:
8069096
41.
42.

An analysis of a melanoma epidemic.

Burton RC, Coates MS, Hersey P, Roberts G, Chetty MP, Chen S, Hayes MH, Howe CG, Armstrong BK.

Int J Cancer. 1993 Nov 11;55(5):765-70.

PMID:
8244573
43.

The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells.

Scalzo AA, Fitzgerald NA, Wallace CR, Gibbons AE, Smart YC, Burton RC, Shellam GR.

J Immunol. 1992 Jul 15;149(2):581-9.

PMID:
1378069
44.

Correlation of growth of tumours in NC-cell-depleted mice with NC- and NK-cell-mediated lysis in vitro.

Smart YC, Farrelly ML, Burton RC.

Int J Cancer. 1992 Mar 12;50(5):817-21.

PMID:
1544715
45.

Studies on murine natural killer (NK) cells. V. Genetic analysis of NK cell markers.

Burton RC, Smart YC, Koo GC, Winn HJ.

Cell Immunol. 1991 Jul;135(2):445-53.

PMID:
2036678
46.

Factors related to the presentation of patients with thick primary melanomas.

Hersey P, Sillar RW, Howe CG, Burton RC, Darbar SV, Foster HM, Collins SM, Bradley DE, Owens D.

Med J Aust. 1991 May 6;154(9):583-7.

PMID:
2056943
47.

Production of a monoclonal allo-antibody to murine natural cytotoxic cells.

Smart YC, Stevenson KL, Farrelly ML, Brien JH, Burton RC.

Immunol Cell Biol. 1990 Aug;68 ( Pt 4):277-84.

PMID:
2249875
48.

Mammary serum antigen (MSA) in advanced breast cancer.

Smart YC, Stewart JF, Bartlett LD, Brien JH, Forbes JF, Burton RC.

Breast Cancer Res Treat. 1990 Jul;16(1):23-8.

PMID:
1698488
49.

Natural cytotoxic cells and tumour surveillance in vivo.

Smart YC, Tooney PA, Farrelly ML, Brien JH, Burton RC.

Eur J Cancer. 1990;26(8):863-4. No abstract available.

PMID:
2145924
50.

Factors affecting MSA levels in normal women and women with breast cancer.

Smart YC, Rogers KM, Brien JH, Stewart JF, Burton RC.

Aust N Z J Surg. 1989 Oct;59(10):805-9.

PMID:
2818340

Supplemental Content

Loading ...
Support Center